Group challenges St. Louis system's uninsured pricing settlement; Study shows no link between measles vaccine and autism;

> Back in March, it seemed like a solution to the long-fought class-action lawsuit was near at hand. Under fire for the prices it charged the uninsured, St. Louis-based BJC Healthcare agreed to give a 25 percent discount to all hospital patients without insurance. But now, it's looking like the settlement might not be good enough for everyone involved. FierceHealthFinance

> Shares of Allergan shot up 13 percent on the news that Botox worked as a therapy for chronic migraines in a late-stage trial. And based on its analysis from two studies, Allergan says it will go to the FDA next year to file an sBLA for an added approval. FierceBiotech

> An influential pharma analyst downgraded Merck shares, saying they've hit their price ceiling. Why? The reasons can be summed up in four drugs: Singulair, Gardasil, taranabant, and Vytorin. FiercePharma

> Columbia University's Mailman School of Public Health looked closely to see if the measles vaccine could trigger autism--and found nothing. FierceVaccines

And Finally... Looks like you can go home again. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.